DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites - PubMed (original) (raw)
Comparative Study
. 2001 Mar 2;276(9):6675-88.
doi: 10.1074/jbc.M001748200. Epub 2000 Oct 26.
Affiliations
- PMID: 11053426
- DOI: 10.1074/jbc.M001748200
Free article
Comparative Study
DNA binding specificity of different STAT proteins. Comparison of in vitro specificity with natural target sites
G B Ehret et al. J Biol Chem. 2001.
Free article
Abstract
STAT transcription factors are expressed in many cell types and bind to similar sequences. However, different STAT gene knock-outs show very distinct phenotypes. To determine whether differences between the binding specificities of STAT proteins account for these effects, we compared the sequences bound by STAT1, STAT5A, STAT5B, and STAT6. One sequence set was selected from random oligonucleotides by recombinant STAT1, STAT5A, or STAT6. For another set including many weak binding sites, we quantified the relative affinities to STAT1, STAT5A, STAT5B, and STAT6. We compared the results to the binding sites in natural STAT target genes identified by others. The experiments confirmed the similar specificity of different STAT proteins. Detailed analysis indicated that STAT5A specificity is more similar to that of STAT6 than that of STAT1, as expected from the evolutionary relationships. The preference of STAT6 for sites in which the half-palindromes (TTC) are separated by four nucleotides (N(4)) was confirmed, but analysis of weak binding sites showed that STAT6 binds fairly well to N(3) sites. As previously reported, STAT1 and STAT5 prefer N(3) sites; however, STAT5A, but not STAT1, weakly binds N(4) sites. None of the STATs bound to half-palindromes. There were no specificity differences between STAT5A and STAT5B.
Similar articles
- A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B.
Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S, Chretien S. Verdier F, et al. Mol Cell Biol. 1998 Oct;18(10):5852-60. doi: 10.1128/MCB.18.10.5852. Mol Cell Biol. 1998. PMID: 9742102 Free PMC article. - A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities.
Boucheron C, Dumon S, Santos SC, Moriggl R, Hennighausen L, Gisselbrecht S, Gouilleux F. Boucheron C, et al. J Biol Chem. 1998 Dec 18;273(51):33936-41. doi: 10.1074/jbc.273.51.33936. J Biol Chem. 1998. PMID: 9852045 - Distinct palindromic extensions of the 5'-TTC...GAA-3' motif allow STAT6 binding in vivo.
Kraus J, Börner C, Höllt V. Kraus J, et al. FASEB J. 2003 Feb;17(2):304-6. doi: 10.1096/fj.02-0482fje. Epub 2002 Dec 3. FASEB J. 2003. PMID: 12475891 - Functional roles of STAT family proteins: lessons from knockout mice.
Akira S. Akira S. Stem Cells. 1999;17(3):138-46. doi: 10.1002/stem.170138. Stem Cells. 1999. PMID: 10342556 Review. - Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation.
Grimley PM, Dong F, Rui H. Grimley PM, et al. Cytokine Growth Factor Rev. 1999 Jun;10(2):131-57. doi: 10.1016/s1359-6101(99)00011-8. Cytokine Growth Factor Rev. 1999. PMID: 10743504 Review.
Cited by
- STAT3 suppresses transcription of proapoptotic genes in cancer cells with the involvement of its N-terminal domain.
Timofeeva OA, Tarasova NI, Zhang X, Chasovskikh S, Cheema AK, Wang H, Brown ML, Dritschilo A. Timofeeva OA, et al. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1267-72. doi: 10.1073/pnas.1211805110. Epub 2013 Jan 3. Proc Natl Acad Sci U S A. 2013. PMID: 23288901 Free PMC article. - DNA binding reduces the dissociation rate of STAT1 dimers and impairs the interdimeric exchange of protomers.
Riebeling T, Staab J, Herrmann-Lingen C, Meyer T. Riebeling T, et al. BMC Biochem. 2014 Dec 20;15:28. doi: 10.1186/s12858-014-0028-z. BMC Biochem. 2014. PMID: 25526807 Free PMC article. - Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular disease.
Szelag M, Piaszyk-Borychowska A, Plens-Galaska M, Wesoly J, Bluyssen HA. Szelag M, et al. Oncotarget. 2016 Jul 26;7(30):48788-48812. doi: 10.18632/oncotarget.9195. Oncotarget. 2016. PMID: 27166190 Free PMC article. Review. - Identification of co-occurring transcription factor binding sites from DNA sequence using clustered position weight matrices.
Oh YM, Kim JK, Choi S, Yoo JY. Oh YM, et al. Nucleic Acids Res. 2012 Mar;40(5):e38. doi: 10.1093/nar/gkr1252. Epub 2011 Dec 19. Nucleic Acids Res. 2012. PMID: 22187154 Free PMC article. - Signal transducers and activators of transcription 5 contributes to erythropoietin-mediated neuroprotection against hippocampal neuronal death after transient global cerebral ischemia.
Zhang F, Wang S, Cao G, Gao Y, Chen J. Zhang F, et al. Neurobiol Dis. 2007 Jan;25(1):45-53. doi: 10.1016/j.nbd.2006.08.007. Epub 2006 Sep 27. Neurobiol Dis. 2007. PMID: 17008107 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous